Speakers & Agenda

  1:15pm – 1:50pm ET

Keynote Presentation

Alan Cohen, General Partner, DCVC

This session will offer an overview of the emerging Techmed space and compare it with the traditional Medtech market. It will emphasize the potential for innovation and growth within this rapidly evolving sector.

  1:50pm – 2:25pm ET

Strategic Biotech Investments

Ketan Patel, M.D., Managing Partner, F-Prime Capital

This session will provide insights on early-stage biotech venture capital investing, highlighting key strategies for identifying high-potential opportunities in this rapidly evolving sector.

  2:25pm – 3:00pm ET

Innovations in Biotech:
A Look into Recursion’s AI-Driven Approach

Ryan Subaran, Senior Scientist, Computational Oncology, Recursion

This session will highlight Recursion’s use of AI and high-throughput systems biology to drive innovations in the tech-bio space. Attendees will learn how the company is leveraging cutting-edge genomics technologies and active learning to understand biological networks and accelerate drug development pipelines.

  3:00pm – 3:10pm ET

  3:10pm – 3:45pm ET

Tech Trends Driven by Emerging Healthcare Models

Rose Ritts, Managing Director, BVCC

An overview of the key challenges and emerging trends in US Healthcare, with key insights into the tech and investment opportunities being driven by these trends.

  3:45pm – 4:20pm ET

Strategic Medtech Investments

Jake Pflaum, Partner, American Century Investments

This session will explore strategic investment opportunities in Medtech, focusing on key trends and strategies for identifying high-potential areas for returns in this dynamic sector.

  4:20pm – 4:55pm ET

  4:55pm  – 5:30pm ET